Catherine M. Szyman - 03 May 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 03 May 2023
Net transactions value: -$59,020
Form type: 4
Filing time: 04 May 2023, 21:49:46 UTC
Previous filing: 13 Feb 2023
Next filing: 09 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	$28,714	-327	-1.2%	$87.81	27,697	03 May 2023	Direct
transaction	EW	Common Stock	Tax liability	$30,306	-344	-1.2%	$88.10	27,353	04 May 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.